| Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention LH Cavallari, CR Lee, AL Beitelshees, RM Cooper-DeHoff, JD Duarte, ... JACC: Cardiovascular Interventions 11 (2), 181-191, 2018 | 263 | 2018 |
| Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients C Yau, M Osdoit, M van der Noordaa, S Shad, J Wei, D de Croze, ... The Lancet Oncology 23 (1), 149-160, 2022 | 201 | 2022 |
| Association of event-free and distant recurrence–free survival with individual-level pathologic complete response in neoadjuvant treatment of stages 2 and 3 breast cancer … D Yee, AM DeMichele, C Yau, C Isaacs, WF Symmans, KS Albain, ... JAMA oncology 6 (9), 1355-1362, 2020 | 140 | 2020 |
| Molecular pathology of colorectal cancer S Harada, D Morlote Advances in anatomic pathology 27 (1), 20-26, 2020 | 113 | 2020 |
| Implementation and utilization of the molecular tumor board to guide precision medicine S Harada, R Arend, Q Dai, JA Levesque, TS Winokur, R Guo, MJ Heslin, ... Oncotarget 8 (34), 57845, 2017 | 80 | 2017 |
| Differential regulation of early growth response gene-1 expression by insulin and glucose in vascular endothelial cells RN Hasan, S Phukan, S Harada Arteriosclerosis, thrombosis, and vascular biology 23 (6), 988-993, 2003 | 72 | 2003 |
| Insulin-induced protein tyrosine phosphorylation cascade and signalling molecules are localized in a caveolin-enriched cell membrane domain RM Smith, S Harada, JA Smith, S Zhang, L Jarett Cellular signalling 10 (5), 355-362, 1998 | 71 | 1998 |
| EGFR and KRAS mutations in metastatic lung adenocarcinomas D Munfus-McCray, S Harada, C Adams, F Askin, D Clark, E Gabrielson, ... Human pathology 42 (10), 1447-1453, 2011 | 69 | 2011 |
| Inhibition of insulin-degrading enzyme increases translocation of insulin to the nucleus in H35 rat hepatoma cells: evidence of a cytosolic pathway S Harada, RM Smith, JA Smith, L Jarett Endocrinology 132 (6), 2293-2298, 1993 | 64 | 1993 |
| Insulin-induced egr-1 and c-fos expression in 32D cells requires insulin receptor, Shc, and mitogen-activated protein kinase, but not insulin receptor substrate-1 and … S Harada, RM Smith, JA Smith, MF White, L Jarett Journal of Biological Chemistry 271 (47), 30222-30226, 1996 | 61 | 1996 |
| Randomized trial of weight loss in primary breast cancer: Impact on body composition, circulating biomarkers and tumor characteristics W Demark‐Wahnefried, LQ Rogers, JT Gibson, S Harada, AD Frugé, ... International journal of cancer 146 (10), 2784-2796, 2020 | 49 | 2020 |
| ERBB2 mutation is associated with a worse prognosis in patients with CDH1 altered invasive lobular cancer of the breast Z Ping, GP Siegal, S Harada, IE Eltoum, M Youssef, T Shen, J He, ... Oncotarget 7 (49), 80655, 2016 | 45 | 2016 |
| Mechanisms of nuclear translocation of insulin S Harada, RM Smith, L Jarett Cell biochemistry and biophysics 31, 307-319, 1999 | 45 | 1999 |
| The significance of HER‐2/neu receptor positivity and immunophenotype in ductal carcinoma in situ with early invasive disease S Harada, R Mick, RE Roses, H Graves, H Niu, A Sharma, JE Schueller, ... Journal of surgical oncology 104 (5), 458-465, 2011 | 42 | 2011 |
| Poor cell block adequacy rate for molecular testing improved with the addition of D iff‐Q uik–stained smears: Need for better cell block processing S Harada, E Agosto‐Arroyo, JA Levesque, E Alston, KM Janowski, ... Cancer Cytopathology 123 (8), 480-487, 2015 | 38 | 2015 |
| Electron microscopic visualization of insulin translocation into the cytoplasm and nuclei of intact H35 hepatoma cells using covalently linked Nanogold-insulin N Shah, S Zhang, S Harada, RM Smith, L Jarett Endocrinology 136 (7), 2825-2835, 1995 | 38 | 1995 |
| Differential modulation of the tyrosine phosphorylation state of the insulin receptor by IRS (insulin receptor subunit) proteins BT Solow, S Harada, BJ Goldstein, JA Smith, MF White, L Jarett Molecular endocrinology 13 (10), 1784-1798, 1999 | 34 | 1999 |
| The utility of phosphohistone H3 in breast cancer grading X Cui, S Harada, D Shen, GP Siegal, S Wei Applied Immunohistochemistry & Molecular Morphology 23 (10), 689-695, 2015 | 32 | 2015 |
| Nonreceptor mediated nuclear accumulation of insulin in H35 rat hepatoma cells S Harada, EG Loten, RM Smith, L Jarett Journal of cellular physiology 153 (3), 607-613, 1992 | 32 | 1992 |
| Abstract GS3-08: Pathological complete response predicts event-free and distant disease-free survival in the I-SPY2 TRIAL D Yee, A DeMichele, C Isaacs, F Symmans, C Yau, KS Albain, NM Hylton, ... Cancer Research 78 (4_Supplement), GS3-08-GS3-08, 2018 | 31 | 2018 |
